Skip to main content
Premium Trial:

Request an Annual Quote

BC Platforms, UK Biobank Organization to Codevelop Research Platform

NEW YORK (GenomeWeb) – Swiss genomic data management firm BC Platforms announced today that it is collaborating with the UK Clinical Research Collaboration Tissue Directory and Coordination Centre (UKCRC TDCC) to develop a unique biobank research platform.

The platform will be based on the company's BC|Rquest system for analyzing and viewing aggregated genomic and clinical data from multiple biobanks. The partners said that the new platform will be made available to more than 150 of the organization's member biobanks in the UK.

Additional terms of the deal were not disclosed.

"The collaboration with BC Platforms facilitates the rapid exchange of information amongst our members and allows them to efficiently manage and grow their collections," UKCRC TDCC Director Philip Quinlan said in a statement. "BC|Rquest offers our biobanks and researchers a way to identify available samples quickly, test hypotheses on combined data assets, and collaborate on important research endeavors."

BC Platforms began developing BC|Rquest as part of its involvement in ESCAPE-NET, a European Union-funded effort to assemble a large-scale genomic database devoted exclusively to the study of sudden cardiac arrest.

The Scan

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.